Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ERIC SAMUEL NADLER

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1134161243
CMS profile
96406
Location
DALLAS, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$233,568.34

197 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

By paying entity

PY2022 · entire year · sorted by reported total

Paying entityAmountRecords
Genentech USA, Inc. $66,478.62 39
G1 Therapeutics, Inc. $55,321.50 55
AstraZeneca Pharmaceuticals LP $38,533.24 39
JAZZ PHARMACEUTICALS INC. $26,841.42 25
GENZYME CORPORATION $12,520.33 10
Lilly USA, LLC $10,359.90 9
Regeneron Healthcare Solutions, Inc. $10,295.72 13
Seagen Inc. $8,000.00 2
EISAI INC. $4,590.00 1
Blueprint Medicines Corporation $462.00 1
Novocure Inc. $133.49 1
Novartis Pharmaceuticals Corporation $32.12 2

Page 2 of 4; records 51–100 of 197 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ERIC SAMUEL NADLER

NPI 1134161243 · CMS profile ID 96406

Allopathic & Osteopathic Physicians / Internal Medicine / Medical Oncology

DALLAS, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 4; records 51–100 of 197 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1134161243?year=2022&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ERIC SAMUEL NADLER, NPI 1134161243, CMS profile ID 96406. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 197 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1134161243?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). ERIC SAMUEL NADLER, NPI 1134161243, CMS profile ID 96406. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 197 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1134161243?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
ERIC SAMUEL NADLER, NPI 1134161243, CMS profile ID 96406, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 4; records 51–100 of 197 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1134161243?year=2022&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

197 matching records · $233,568.34 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 197 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 197.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
JAZZ PHARMACEUTICALS INC. $159.9510/05/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951401769 CMS
JAZZ PHARMACEUTICALS INC. $1,590.0010/05/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951401791 CMS
JAZZ PHARMACEUTICALS INC. $1,590.0010/05/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951401793 CMS
JAZZ PHARMACEUTICALS INC. $137.7510/04/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951401779 CMS
JAZZ PHARMACEUTICALS INC. $142.7510/03/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951401775 CMS
JAZZ PHARMACEUTICALS INC. $429.2510/03/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951401777 CMS
Novartis Pharmaceuticals Corporation $13.2009/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894009557 CMS
Regeneron Healthcare Solutions, Inc. $2,318.0009/30/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 927296563 CMS
Seagen Inc. $1,200.0009/30/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 904130341 CMS
AstraZeneca Pharmaceuticals LP $450.0009/22/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920242521 CMS
G1 Therapeutics, Inc. $4,415.0009/22/2022 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954036075 CMS
G1 Therapeutics, Inc. $53.3909/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954036139 CMS
G1 Therapeutics, Inc. $121.8109/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954036147 CMS
G1 Therapeutics, Inc. $80.0009/22/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954036213 CMS
G1 Therapeutics, Inc. $134.0009/22/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954036225 CMS
G1 Therapeutics, Inc. $217.1309/22/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954036233 CMS
G1 Therapeutics, Inc. $306.1309/22/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954036241 CMS
G1 Therapeutics, Inc. $514.2009/22/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954036245 CMS
AstraZeneca Pharmaceuticals LP $1,050.0008/29/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920245585 CMS
AstraZeneca Pharmaceuticals LP $1,050.0008/29/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920252869 CMS
AstraZeneca Pharmaceuticals LP $2,700.0008/24/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920225163 CMS
AstraZeneca Pharmaceuticals LP $150.0008/24/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920250945 CMS
JAZZ PHARMACEUTICALS INC. $91.7008/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951401755 CMS
JAZZ PHARMACEUTICALS INC. $12.5008/22/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951401757 CMS
JAZZ PHARMACEUTICALS INC. $10.0008/22/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951401759 CMS
JAZZ PHARMACEUTICALS INC. $3,710.0008/22/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951401761 CMS
G1 Therapeutics, Inc. $4,415.0008/17/2022 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954036071 CMS
G1 Therapeutics, Inc. $44.9408/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954036135 CMS
G1 Therapeutics, Inc. $93.8408/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954036141 CMS
G1 Therapeutics, Inc. $80.0008/17/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954036217 CMS
G1 Therapeutics, Inc. $88.9808/17/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954036221 CMS
G1 Therapeutics, Inc. $155.1308/17/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954036229 CMS
G1 Therapeutics, Inc. $258.7908/17/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954036237 CMS
JAZZ PHARMACEUTICALS INC. $338.6108/16/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951401773 CMS
JAZZ PHARMACEUTICALS INC. $87.3508/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951401783 CMS
JAZZ PHARMACEUTICALS INC. $182.3608/01/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951401785 CMS
Lilly USA, LLC $1,250.0007/29/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918027369 CMS
JAZZ PHARMACEUTICALS INC. $3,710.0007/27/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951401781 CMS
G1 Therapeutics, Inc. $1,725.0007/21/2022 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954036067 CMS
AstraZeneca Pharmaceuticals LP $89.3207/16/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920252033 CMS
Novocure Inc. $133.4907/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 953393429 CMS
AstraZeneca Pharmaceuticals LP $250.0007/13/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920223367 CMS
AstraZeneca Pharmaceuticals LP $250.0007/13/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920244555 CMS
JAZZ PHARMACEUTICALS INC. $3,710.0007/05/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951401747 CMS
JAZZ PHARMACEUTICALS INC. $5.8507/05/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951401751 CMS
JAZZ PHARMACEUTICALS INC. $20.0007/05/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951401753 CMS
AstraZeneca Pharmaceuticals LP $2,150.0007/03/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920259761 CMS
G1 Therapeutics, Inc. $3,415.0006/30/2022 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954036049 CMS
G1 Therapeutics, Inc. $50.0006/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954036111 CMS
G1 Therapeutics, Inc. $143.3806/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954036123 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $275,331.56 224
PY2020 $147,448.40 96
PY2021 $233,948.76 184
PY2022 $233,568.34 197
PY2023 $219,310.18 199
PY2024 $237,654.88 194
PY2025 $211,498.36 129

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $16,177.20 1
PY2024 Principal investigator $15,750.00 1
PY2022 Principal investigator $70,322.10 1
PY2021 Principal investigator $408,300.00 8
PY2020 Principal investigator $559,279.79 9
PY2019 Principal investigator $435,295.00 5

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

1 record in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 AstraZeneca Pharmaceuticals LP $16,177.20 11/13/2025 Non-covered Recipient Entity
TEXAS ONCOLOGY, PA
a phase 3b,randomized,multicenter,open label study to assess the efficacy of durvalumab plus tremelimumab versus pembrolizumab in combination with platinum based chemotherapy for first line treatment in mtastatic non small cell lung cancer patients with non squamous histology who have mutations and or co mutations in skt11,keap1,or kras triton No dispute reported 06/30/2026 1185541380